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Cytokines as Diagnostic Biomarkers in Canine Pyometra and 
Sepsis 
Abstract 
Sepsis is a syndrome with high morbidity, mortality and astronomical health care costs 
and it is challenging to diagnose both in humans and animals due to the lack of suitable 
diagnostic biomarkers. Although several types of proteins have been suggested as 
diagnostic biomarkers of sepsis, none of them were shown to be reliable for routine use 
in the clinical practice. Dogs with uterine bacterial infection called pyometra often 
develop sepsis and have been suggested as a natural model of sepsis. To investigate 
whether there is a pattern of biomarkers that can be useful to diagnose bacterial sepsis 
on early stages in addition to existing clinical criteria, we measured both local gene 
expression and serum levels of cytokines in dogs with pyometra and compared these 
levels with known inflammatory markers and blood clotting parameters. 
Serum concentrations of keratinocyte-derived chemokine (KC)-like protein and the 
global clot strength were significantly increased both in dogs with pyometra compared 
to healthy dogs and in dogs with sepsis compared to dogs without sepsis in pyometra. 
Moreover, the expression levels of the chemokines interleukin (IL)-8 and C-X-C motif 
ligand 5 (CXCL5) mRNA were significantly higher in uteri from dogs with pyometra 
compared to healthy dogs and in cultured stromal endometrial cells derived from uteri 
of healthy dogs and cocultured with LPS or pathogenic Escherichia coli compared to 
unstimulated cells. Although serum concentrations of IL-8, high-mobility group box 1 
(HMGB1), prostaglandin F2α, IL-2, IL-15, IL-18, interferon (IFN)-γ and monocyte-
macrophage colony stimulating factor (MG-CSF) were not different between dogs with 
or without sepsis in the presence of pyometra, some of these cytokines correlated 
significantly with clinical parameters such as total white blood cell count (correlated 
with HMGB1) and KC-like (correlated with IL-8). Measurements of serum IL-10, 
CXCL10, tumor necrosis factor (TNF)-α, IL-6 and IL-4 will require a more sensitive 
method in dogs with pyometra.  
Our findings suggest that KC-like, CXCL5 and IL-8 may be useful as early 
diagnostic biomarkers of sepsis in dogs with pyometra. Further investigation of these 
chemokines in sepsis may help to improve routines in sepsis diagnosis in dogs and 
possibly also humans. 
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C-reactive protein 
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PAMP 
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NK 
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Cecal ligation and puncture 
Pathogen-associated molecular pattern 
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Systemic inflammatory response syndrome 
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GM-CSF Granulocyte-macrophage colony stimulating factor 
HMGB1 High-mobility group box 1 
IFN Interferon 
IL Interleukin 
LPS Lipopolysaccharide 
Th T helper 
TNF Tumor necrosis factor 
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1 Introduction 
The incidence, severity and mortality rates in sepsis in both humans and 
animals are rising worldwide despite an increasing body of knowledge on 
sepsis pathophysiology and numerous experimental and clinical studies 
investigating sepsis. Current experimental models of sepsis provide 
considerable knowledge but are not able to reflect the actual clinical scenario 
of sepsis syndrome onset and progression, and the findings obtained in these 
models are often not directly applicable for clinical patients with sepsis. The 
major problem in sepsis remains the weakness of the clinical diagnostic criteria 
that account for the delays in life-saving treatment initiation and erroneous 
choice of treatment strategy for a given patient. Many biological molecules 
have been tested for the ability to predict the onset of sepsis and distinguish 
between sterile and infection-caused inflammation in order to minimize the use 
of broad-spectrum antibiotics and improve both short-term and long-term life 
quality of the patients. However, none of the evaluated biomarkers can be 
recommended for routine clinical use in specific diagnosis of sepsis (Bloos, 
2015). Cytokines constitute a large group of biological molecules that 
participate actively in the immune response towards an infection in the body. 
The search for a pattern of cytokines associated with exacerbation of infection 
and the onset of sepsis syndrome that could contribute to an early and specific 
diagnosis of sepsis is currently intense. In this thesis several cytokines are 
examined as diagnostic biomarkers in naturally occurring canine sepsis caused 
by uterine bacterial infection, i.e. pyometra.  
1.1 Cytokines 
1.1.1 Definition 
Cytokines are small protein molecules (5-20 kDa) that are produced and 
released by a great variety of cells in the body with the main purpose of 
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providing communication between cells (Cameron & Kelvin, 2003). A broad 
range of cells, including immune cells like macrophages, B lymphocytes, T 
lymphocytes and mast cells, as well as endothelial cells, fibroblasts, and 
various stromal cells can produce and release cytokines. Some cytokines can 
be produced by a limited number of cell types, whereas others - by virtually all 
known cell types. A given cytokine may be produced by more than one type of 
cell, and every cytokine is recognized by one or more receptors.  
The production and release of cytokines from immune cells and other cells 
are critical for an efficient and well-orchestrated response to inflammation and 
infection in the body, which is why cytokines are considered to be 
immunomodulating (Meide & Schellekens, 1996). Cytokines can work at both 
systemic and local levels.  
Based on function, cell of origin, or target of action, cytokines can be 
classified as interleukins (ILs), interferons (IFNs), tumor necrosis factors 
(TNFs) and chemokines. Interleukins are made primarily by leukocytes and act 
primarily on other leukocytes. Tumor necrosis factors can facilitate apoptotic 
cell death. Chemokines mediate chemoattraction (chemotaxis) between cells 
and interferons can “interfere” with viral replication, activate certain immune 
cells and increase antigen presentation (De Andrea et al., 2002). 
Chemokines is a large and diverse group of cytokines and it can be further 
subdivided into C-X-C (CXC), C-C (CC), X-C (XC), and C-3X-C (CXXXC) 
motif chemokines depending on the arrangement of the first two invariant 
cysteine residues in the amino acid sequence. This means that many 
chemokines share structural properties, but their chemotactic effects were 
shown to be diverse (Charo & Ransohoff, 2006). The CXC chemokines 
comprise one of the largest chemokine groups and can be produced by a great 
variety of both stimulated and unstimulated cells. There are two kinds of CXC 
chemokines, ELR+ and ELR-, based on whether or not the N-terminal 
sequences contain glutamic acid–leucine–arginine (ELR) motif in front of the 
first cysteine (Laing & Secombes, 2004). One particular property of ELR+ 
CXC chemokines is that they are specialized in attracting and activating 
neutrophils (Baggiolini et al. 1991; Huber et al., 1991), but also other immune 
cells such as basophils, eosinophils, NK cells and some T lymphocytes. ELR- 
CXC chemokines, on the other hand, attract mainly lymphocytes and 
monocytes and have a limited chemoattracting effect on neutrophils (Laing & 
Secombes, 2004).  
Cytokines are important in health and disease, and knowledge on their 
involvement in host responses to infection, inflammation, trauma, cancer, 
reproduction and sepsis is of a great importance.  
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1.1.2 Cytokines in bacterial infection 
Some cytokines are produced constitutively, but most of them are produced as 
a result of induction. A wide variety of factors including bacteria, viruses, other 
microbes and even other cytokines can stimulate various cells to produce one, a 
few, or many cytokines, which can in turn activate or inactivate other cells and 
affect the inflammatory response through a chain reaction (Chen et al., 2014).  
In a bacterial infection, the first immune cells responding are monocytes and 
macrophages, which upon activation by bacteria or bacterial products respond 
almost immediately by production of cytokines such as TNF-α, IL-1 and IL-6 
(Russel et al., 2010) (Figure 1). These cytokines activate and amplify the 
inflammatory response towards the infection and facilitate production of other 
inflammatory cytokines and chemokines, including IL-8, IL-12, IL-15 and IL-18, 
with the main purpose to attract and activate other immune cells, such as 
neutrophils and natural killer cells (Cohen, 2002). On later stages of an immune 
response to bacterial infection cells of the adaptive immunity, i.e. T and B 
lymphocytes, are activated in the lymph nodes and migrate to the site of infection. 
Lymphocytes need also to communicate with each other and with other immune 
cells, which is why they also produce a number of cytokines such as IL-2, IL-4, IL-
5, IL-6 and IFN-γ (Zhu & Paul, 2008). The pro-inflammatory immune response 
must be counter balanced by an anti-inflammatory response manifested by the 
release of cytokines such as IL-10 produced by many types of immune cells 
including macrophages, dendritic cells, and different types of lymphocytes (Cohen, 
2002; Shubin et al., 2011). 
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Figure 1. Cytokines and chemokines are released by several types of immune cells in response to 
bacterial infection and other stimuli. Tissue macrophages are one of the first cells that react to 
infection by producing and releasing cytokines. Macrophages initiate an immune response by 
recruiting and activating other immune cells such as neutrophils and lymphocytes. If the cell 
communication is impaired, lymphocytes, macrophages and neutrophils can loose some of their 
crucial functions, which in turn contributes to an exacerbated and unbalanced inflammatory 
reaction and impaired clearance of bacteria and bacterial products. 
The fact that many cytokines are produced during a bacterial infection and 
that different patterns of cytokines are produced at different time points of 
infection in response to different stimuli makes it interesting for researchers 
and clinicians to measure levels of the cytokines and study these specific 
patterns. For instance, infections caused by different parts of Helicobacter 
pylori and different species of Listeria resulted in the induced mRNA 
expression of different cytokine patterns (Kuhn & Goebel 1994; Xiong et al., 
1994; Imanishi, 2000), and higher levels of type I interferons and TNF-α were 
detected both in vitro and in vivo during infection with different bacteria or 
their products (Degre, 1996). A recent report shows that serum concentrations 
of IL-2, IL-4, TNF-α and IFN-γ increased two-fold and concentrations of IL-6 
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and IL-10 increased more than 10-fold the normal levels in children with Gram 
negative nosocomial infections within 24 h after infection onset and before the 
increase of CRP levels, which is an acute phase protein (Chen et al., 2013). 
Bacterial infections caused by Escherichia coli, Streptococcus pneumonia, 
Chlamydophila pneumonia or Streptococcus agalactiae were associated with 
significantly elevated serum concentrations of cytokines including IL-2, IL-6 
and TNF-α in comparison with the levels observed in sera of patients with 
viral infections (Holub et al., 2013).  
Numerous studies have evaluated the ability of single cytokines to detect 
certain bacterial infections with high sensitivity in early stage of infection or 
assisting in infection prognoses (Chen et al., 2013), including TNF-α and IFN-
γ (Stoycheva & Murdjeva, 2005), IL-6 and IL-8 (Tavares et al., 2005; 
Ventetuolo & Levy, 2008; Jacovides et al., 2011), IL-12 and IL-18 (Sánchez-
Hernández et al., 2011), keratinocyte-derived chemokine (KC) (Huang et al., 
1992; Songlih et al., 1992; Kim et al., 2005), epithelial-derived neutrophil-
activating protein (ENA)-78, also named CXCL5 (Nasu et al., 2001; Mei et al., 
2010; Nouailles et al., 2014), IL-17 (van de Veerdonk et al., 2009), high-
mobility group box 1 (HMGB1) (Scaffidi et al., 2002; van Zoelen et al., 
2007; Zhou et al., 2011; Allonso et al., 2012; Yanai et al., 2013), IL-10 
(Couper et al., 2008) and CXCL10, also named INF-γ-inducible protein (IP)-
10 (Proost et al., 2003; Chen et al., 2009). Interestingly, CXCL10 was recently 
suggested for use as an alternative infection marker to IFN-γ, showing 
promising results in more than 20 clinical studies (Ruhwald et al., 2012). 
CXCL10 is an ELR- CXC chemokine produced by different kinds of cells 
including monocytes, endothelial cells and fibroblasts (Farber, 1997). CXCL10 
shows relatively high diagnostic accuracy in infection and is also a reliable 
infection marker in young children and in individuals with low cluster of 
differentiation 4 (CD4+) cell counts (T helper cells, monocytes, macrophages 
and dendritic cells) (Ruhwald et al., 2012). CXCL10 has been suggested to 
have antimicrobial effect both for Gram positive and Gram negative bacteria 
(Yang et al., 2003; Egesten et al., 2007; Cole et al., 2001) and was shown to be 
upregulated in uteri from dogs with uterine bacterial infection (Hagman et al., 
2009b). 
Some of the cytokines that were shown to be useful in detecting or 
monitoring of immune response to bacterial infections may potentially be 
useful in the diagnosis of more severe immunological conditions caused by an 
infection such as sepsis. This may depend on their role, timing of action and 
specificity in sepsis pathogenesis, as well as to what extent they differ 
individually in patients depending on the concurrent conditions and diseases. 
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1.2 Sepsis 
1.2.1 Definition 
Sepsis, also called “blood poisoning” or septicemia, is defined as presence of 
systemic inflammatory response syndrome (SIRS) caused by an infection 
(Bone, 1992; Levy, 2003). Patients with two or more signs of SIRS and 
suspected or confirmed infection are diagnosed as having sepsis. Sepsis can 
further progress into severe sepsis and septic shock. Patients with diagnosed 
sepsis showing evidence of organ dysfunction (cardiovascular, renal, hepatic, 
or neurological) and those with evidence of inadequate tissue perfusion are 
classified as severe sepsis.  Sepsis patients with inadequate tissue perfusion and 
persistently low blood pressure despite intravenous fluid administration are 
classified as having septic shock (Deutschman & Tracey, 2014). Most 
commonly sepsis is caused by Gram negative or Gram positive bacterial 
infections (Martin et al., 2003), but mycobacterial, rickettsial, viral, fungal and 
protozoan infections can also lead to sepsis (King 2007, Martin, 2012). Both 
pathogenic bacteria and commensal microorganisms evading otherwise sterile 
tissues as a result of clinical manipulations such as surgery can cause infection 
that leads to sepsis.  
Sepsis may rapidly lead to death or result in a severely compromised life 
quality when the diagnosis is delayed or the treatment is inefficient (Hotchkiss 
& Karl, 2003; Yende et al., 2014). Being associated with astronomical health 
care costs, sepsis was listed as one of the most expensive condition in 2011 
(Torio & Andrews, 2013). 
 
1.2.2 Epidemiology of sepsis: incidence and outcome 
The incidence and severity of sepsis in humans are increasing worldwide 
(Brun-Buisson et al., 1996; Angus et al., 2001; Danai & Martin, 2005; 
Harrison et al., 2006; Blanco et al., 2008; Esper & Martin, 2009), which is 
likely due to a combination of various factors, including increased awareness 
and tracking of disease conditions, an aging population, increased longevity of 
people with chronic diseases, the emergence and wide spread of antibiotic-
resistant organisms and broader use of immunosuppressive and 
chemotherapeutic agents. It has been recently estimated that sepsis affects 
nearly 27 million people worldwide each year (Colón-Franco & Woodworth, 
2014). 
A decade ago, every third human patient with severe sepsis died (Angus et 
al., 2001), and today the acute mortality rate from sepsis, severe sepsis, and 
septic shock is in average 15%–20% (Kaukonen et al., 2014). The risk of 
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mortality increases by 7.6% every hour for patients with septic shock (Kumar, 
2006). Among sepsis survivors, 75% die within the next 5 years (Iwashyna et 
al., 2010).  
The risk of mortality increases with the increase of sepsis severity: 10-20% 
for sepsis without organ dysfunction or shock, 20-50% for severe sepsis and 
40-80 for septic shock (Martin, 2012). It is therefore of vital importance to 
diagnose sepsis at as early stages as possible.  
 
1.2.3 Immunological response during sepsis 
It was recently highlighted that most of the clinical features of sepsis depend 
vaguely on the nature of the infection, and it appears that the immune response 
of each patient, and not the infecting microorganism, is the key to the 
understanding of sepsis pathogenesis (Faix, 2013; Kinasewitz et al., 2004).  
Initially during an infection, resident immune cells such as macrophages 
generate a pro-inflammatory state in response to pathogen-associated 
molecular patterns (PAMPs) from the infecting organism, and damage-
associated molecular patterns (DAMPs) that are released by damaged host 
cells. Resident immune cells recognize these patterns mainly via Toll-like and 
lectin receptors and then release inflammatory mediators to attract other 
immune cells such as neutrophils and cells of adaptive immunity to the site of 
infection in order to eliminate the pathogen without harming the host (Kumar 
et al., 2011). In most patients, the pro-inflammatory response is self-limiting, 
even in the absence of effective treatment, but in some patients the response 
becomes exaggerated, which leads to sepsis (Faix, 2013).  
At the initial stage sepsis is characterized as a systemic hyperinflammation, 
meaning that the number of activated immune cells in the blood stream 
increases substantially, with the production and release of inflammatory 
mediators at a much higher rate than during a normal infection (Hotchkiss & 
Karl, 2003). As sepsis persists, a shift toward an anti-inflammatory 
immunosuppressive state usually follows (Natanson et al., 1994; Oberholzer et 
al., 2001). Studies on postoperative sepsis, however, suggest that 
immunosuppression can be a primary response in sepsis (Heidecke et al., 1999; 
Weighardt et al., 2000), and there are theories supporting the idea that 
hyperinflammation and immunosuppression in sepsis may occur 
simultaneously (Remick, 2007), which stresses the complexity of the 
inflammatory response in sepsis.  
Factors leading to the onset of sepsis and affecting the overall character of 
the immunological response during sepsis are unknown but may be influenced 
by patient’s age, nutritional status, concurrent diseases and pre-existing 
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immune dysfunctions and genetic factors (Hotchkiss & Karl, 2003). 
Polymorphisms or single base-pair alterations in cytokine genes are thought to 
be important genetic factors that may determine the levels of inflammatory and 
anti-inflammatory cytokines produced, and may influence whether individuals 
have marked hyperinflammatory or hypoinflammatory responses to infection 
(Chung & Waterer, 2011). In particular, the risk of death in sepsis has been 
linked to genetic polymorphisms for tumor necrosis factor (TNF)-α and TNF-β 
(Freeman & Buchman, 2000).  
Activated CD4 T cells are programmed to secrete either T helper (Th)1 
cytokines, including TNF-α, IFN-γ, and IL-2, or Th2 cytokines, such as IL-4 
and IL-10 (Abbas et al., 1996; Opal & DePalo, 2000). Th2 response was 
suggested to be beneficial for survival in sepsis (O’Sullivan et al., 1995), but 
other studies have demonstrated that an increased level of IL-10 in patients 
with sepsis correlates positively with mortality (Gogos et al., 2000). Whether 
CD4 T cells have Th1 or Th2 responses may depend on the virulence of the 
infecting organism, the size of the inoculum, the site of infection, and the 
patient’s condition (Abbas et al., 1996).  
Studies on circulating lymphocyte count in patients with different stages of 
sepsis, and autopsy studies in persons who died of sepsis, showed that large 
numbers of cells of the adaptive immune system and gastrointestinal epithelial 
cells died by apoptosis during sepsis, which occurs primarily during the 
prolonged hypoimmune state (Hotchkiss et al., 1999; Hotchkiss et al., 2002). 
While there is virtually no loss of CD8 T cells, natural killer cells, or 
macrophages, the levels of B cells, CD4 T cells, and follicular dendritic cells 
decrease markedly during sepsis, which in turn leads to decreased antibody 
production, macrophage activation, and antigen presentation, respectively. 
Apoptosis of lymphocytes and gastrointestinal epithelial cells is normal for the 
body and facilitates a rapid cell turnover, which in sepsis accelerates to 
extreme levels and leads to unbalance. Apoptotic cells induce anergy, i.e. 
nonresponsiveness to pathogen, or facilitate the dominance of anti-
inflammatory cytokines that impair the response to pathogens and increase the 
risk of lethal outcome (Voll et al., 1997). Examination of spleens removed 
after death from patients with sepsis demonstrated that the more prolonged 
sepsis, the more profound was the loss of lymphocytes (Hotchkiss et al., 2001).  
Another cell type that has been shown to contribute to sepsis pathogenesis 
is the neutrophil (Remick et al., 2007). Both neutrophil migration and activity 
regulation can be impaired in septic patients. An elevated responsiveness of 
neutrophils to IL-8 and increased expression of IL-8 receptor CXCR2 can 
cause an exacerbated recruitment and activation of neutrophils at the site of 
inflammation. Together with a delay in apoptosis and overexpression of 
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adhesion integrins, neutrophils fail in diapedesis and instead accumulate along 
the surface of endothelium, causing serious damage to the vessel wall by 
releasing toxic amounts of active mediators that were originally produced for 
neutralization of bacteria. A decreased responsiveness of neutrophils to IL-8 
can also occur in patients with sepsis, leading to impaired neutrophil 
recruitment and failure in bacterial clearance. The nonresponsiveness of 
neutrophils to the chemotactic and activating stimuli is a general characteristic 
of a hypoinflammatory sepsis and is commonly detected in patients with septic 
shock (Chishti et al., 2004). 
Taken together, the findings on pathophysiology and immunology of sepsis 
available up to date indicate that both the diagnosis and treatment of sepsis 
during the hyperinflammatory phase may be beneficial and even life-saving 
(Natanson et al., 1994).   
 
1.2.4 Diagnosis 
Despite the advanced technology and vast amount of knowledge currently 
available in the XXIst century, the diagnosis of sepsis remains primitive and 
unspecific. To diagnose sepsis, two or more SIRS criteria must be fulfilled, 
which include elevated heart and respiratory rates, abnormal number of 
leukocytes in the blood stream (leukopenia or leukocytosis) and fever or 
hypothermia, both in humans (Levy, 2003) and in animals such as dogs 
(Hauptman et al., 1997), and an infection either suspected or clinically evident 
in a patient. In other words, it is enough, for instance, that the patient with a 
suspected infection has an elevated respiratory rate and fever, for sepsis to be 
diagnosed. Such criteria are vague and unspecific, because other conditions 
such as trauma or burns that lead to systemic inflammation can also cause 
elevated heart rate, respiratory rate, elevated number of leukocytes and even 
fever. Importantly, the symptoms and clinical manifestations vary considerably 
between patients and depend on type of pathogen, genetic factors, age, and 
nutritional factors as well as the health status of the patient (Hotchkiss & Karl, 
2003). Moreover, some patients with sepsis, especially elderly, never develop 
fever (Gleckman & Hibert, 1982).  
To verify systemic infection and to identify infecting pathogen, several sets 
of blood cultures using media for aerobic and anaerobic organisms are usually 
obtained, with at least one blood sample drawn through the skin and one blood 
sample drawn through a vascular access device that has been in place for more 
than 48 hours (Dellinger et al., 2013). However, blood cultures usually require 
several days before they can be evaluated and are successful only in less than 
50% of cases of late stages of sepsis, and almost completely unsuccessful in 
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early stages of sepsis both in humans (Previsdomini et al., 2012) and in 
animals such as domestic dogs (Heilmann et al., 2013). This makes blood 
cultures unreliable for a quick and precise diagnosis of sepsis. A novel method 
of pathogen detection in blood based on polymerase chain reaction (PCR) was 
developed recently that allows a faster retrieval of results and higher sensitivity 
and specificity compared to blood cultures (Chang et al., 2013; Heilmann et 
al., 2013). However, some clinical studies show that the PCR method has a 
high error frequency (Paolucci et al., 2012), high cost, and the sensitivity 
varied greatly for different pathogens (Paolucci et al., 2012; Chang et al., 
2013; Scvark et al., 2013), which is why it has not yet been recommended as a 
replacement for blood cultures.  
As a consequence of the unspecific diagnostic criteria for sepsis, many 
patients, both human and animal, get an erroneous or delayed diagnosis in 
intensive care units. The false-negative diagnosis, i.e. when the patient that 
actually has sepsis does not satisfy the clinical criteria for SIRS at the time of 
clinical examination and is therefore diagnosed as not having sepsis, may lead 
to the progression of sepsis to more severe conditions or death. The effects of 
false-positive diagnosis in sepsis should not be underestimated either. When a 
patient with noninfectious inflammatory condition is falsely diagnosed as 
having sepsis, unnecessary massive doses of broad-spectrum antibiotics are 
administered. This leads to overuse of antibiotics and in turn an enriched pool 
of antibiotic-resistant pathogens, an increased number of patients with 
infections nonresponsive to antibiotic treatment, and consequently, a 
continuous increase of mortality in sepsis. The need for novel criteria that will 
allow for early and specific diagnosis of sepsis is thus urgent (Khair, 2010).  
 
1.2.5 Biomarkers of sepsis 
Biomarkers, or biological markers, have been defined as cellular, biochemical 
or molecular alterations measurable in biological media such as tissues, cells, 
or body fluids, that can be objectively evaluated as an indicator of normal 
biological processes, pathogenic processes, or pharmacological response to a 
therapeutic intervention (Mayeux, 2004). Biomarkers can yield an 
understanding of the onset prediction, cause, diagnosis, progression, 
regression, or outcome of treatment of a given disease. A perfect biomarker 
would have a high diagnostic accuracy (sensitivity and specificity) especially 
on early stages of the disease, help to make rapid and correct bed-side 
therapeutic decisions and allow to monitor the patient’s response to therapy at 
low cost (Scvark et al., 2013). Among the most important features of a sepsis 
biomarker in particular include the ability to early identify patients with sepsis 
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in a population with systemic inflammatory response syndrome, the ability to 
stratify severity of sepsis and reflect the responsiveness to therapy (Colón-
Franco & Woodworth, 2014).  
More than 180 biomarkers have been investigated in sepsis up to date and 
less than 20% of them were assessed specifically for use in the sepsis diagnosis 
(Pierrakos & Vincent, 2010; Reinhart et al., 2012; Singer, 2013; Loonen et al., 
2014; Cho & Choi, 2014). Among them, only five were reported to have 
sensitivity and specificity above 90% (Pierrakos & Vincent, 2010). These five 
biomarkers include 1) integrin CD11b, 2) CD64, an activated 
polymorphonuclear neutrophil cell surface receptor with high affinity for the 
Fc part of the immunoglobulins, 3) T cell-activating cytokine IL-12, 4) 
CXCL10 and 5) the soluble fraction of group II phospholipase A2 (PLA2-II). 
PLA2-II was the only biomarker among those with the sensitivity and 
specificity above 90% that could distinguish between bacteremic and 
nonbacteremic infection in adults (Rintala et al., 2001). CD64 was the only one 
that showed high accuracy in nonpediatric patients, i.e. in adults. However, the 
concentrations of PLA2-II were not assessed in patients with noninfectious 
inflammation, which makes it uncertain with respect to specificity to the 
presence of infection. Moreover, CD64 had low accuracy in distinguishing 
between viral and bacterial infections (Cardelli et al., 2007; Nuutila et al., 
2007), which is not helpful for the choice of antimicrobial treatment in sepsis.  
CRP and procalcitonin 
Acute phase proteins, such as CRP and procalcitonin, are among the most 
extensively studied biomarkers in clinical sepsis, although their sensitivity and 
specificity for the sepsis diagnosis is typically below 90% (Pierrakos & 
Vincent, 2010). CRP is a protein produced in liver after the onset of 
inflammation and binds to dead or dying cells and some types of bacteria 
(Pepys et al., 2003; Thompsom et al., 1999). CRP concentrations in the blood 
are routinely measured in both human and veterinary clinics. Increased 
circulating concentrations of CRP were detected both in humans and animals 
during inflammation and infection (Epstein et al., 1999; Clyne & Olshaker, 
1999; Pomorska-Mól et al., 2013; Nakamura et al., 2008), and monitoring CRP 
concentrations in humans with sepsis allows evaluation of the efficiency of 
antimicrobial treatment (Schmit et al., 2008; Póvoa et al., 2011). However, 
CRP is released regardless of infectious or noninfectious origin of 
inflammation (Pepys & Baltz, 1983; Vigushin et al., 1993; Clyne & Olshaker, 
1999; Au-Yong, 2012). Low concentrations of CRP cannot safely be used to 
exclude the presence of infection (Chan et al., 2002), which makes CRP 
unreliable in sepsis diagnosis.  
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Procalcitonin, a precursor peptide for the hormone calcitonin, has been 
shown to be significantly increased during microbial infections, having 
particularly higher sensitivity and specificity than CRP for detection of 
bacterial infections (Simon et al., 2004). Earlier studies have shown that 
procalcitonin could differentiate between sepsis and SIRS of noninfectious 
origin (Al-Nawas et al., 1996; Karzai et al., 1997; Brunkhorst et al., 2000), 
differentiate sepsis patients with or without bacteremia (Chirouze et al., 2002; 
Riedel et al., 2011), correlate with severity of bacterial infection (Soreng & 
Levy, 2011) and predict mortality in humans with sepsis (Jain et al., 2014). 
However, recent meta-analyses showed that a high heterogeneity of the reports 
could not be explained, and the suggested cutoff values for procalcitonin 
concentrations varied substantially between the studies (Tang et al., 2007; 
Wacker et al., 2013), as well as between surgical and medical patients (Clec’h 
et al., 2006). Moreover, procalcitonin was shown to be elevated in a number of 
noninfectious disorders such as trauma (Becker et al., 2008), which limits its 
specificity to infection and sepsis. 
Complement system 
Complement proteins have also been studied as biomarkers of sepsis, and 
the concentrations of complement peptide C5a were shown to be elevated in 
murine model of sepsis (Schreiber et al., 2006), and in human patients with 
severe sepsis (Flierl et al., 2008). However, complement proteins are 
participating in many other inflammatory processes in the body, and peptide 
C5a in particular have been used in diagnosis of autoimmune disorders (Yuan 
et al., 2012).  
Lactate 
Serum lactate concentrations can reflect hypoxia and pathologic changes in 
tissue perfusion in severe sepsis and septic shock (Cho & Choi, 2014).  Lactate 
clearance measurement is being widely used in septic patients to monitor 
therapy effectiveness (Jones, 2013), and it was also shown useful in outcome 
prognosis (Nguyen et al., 2004). However, lactate cannot be used to 
differentiate patients with sepsis from those with noninfectious SIRS or to 
diagnose SIRS or sepsis on early stages, which makes its potential as sepsis 
biomarker limited (Nguyen et al., 2004; Colón-Franco & Woodworth, 2014). 
Cytokines and chemokines 
Cytokines, one of the major groups of inflammatory mediators, are 
considered among the potential next-generation biomarkers for sepsis 
diagnosis (Russel & McCulloh, 2012). Analysis of cytokine production in 
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murine experimental model of sepsis and in human patients with sepsis show 
that both pro- and anti-inflammatory cytokines are elevated early in sepsis and 
the levels of cytokines may help to predict outcome (Burkovskiy et al., 2013; 
Schulte et al., 2013; Cabioglu et al., 2002; Osuchowski et al., 2006).  
As pathogens or their toxins enter the blood stream, an unusually powerful 
systemic inflammatory reaction is provoked primarily by the production and 
release of toxic amounts of proinflammatory cytokines, including TNF-α and 
IL-1β. High levels of these cytokines cause an increased neutrophil–
endothelial cell adhesion, overactivation of the clotting mechanism, and 
generation of microthrombi (Hotchkiss & Karl, 2003). Numerous other 
cytokines are then released at higher rates as a result of the exaggerated 
activation loop, which is usually called cytokine cascade or cytokine storm 
(Osterholm, 2005). In such massive pro-inflammatory reaction the importance 
of the negative feedback mechanism in the form of anti-inflammatory cytokine 
release increases consequently (Hotchkiss & Karl, 2003). During the 
immunosuppressive phase of sepsis the cytokine releases will markedly 
decrease, including TNF-α and IL-1β (Ertel et al., 1995). Measurement of 
circulating concentrations of cytokines is therefore thought to be potentially 
useful in evaluating the stage of sepsis, tailoring the administration of anti-
inflammatory agents and predicting outcome (Wang & Ma, 2008; de Pablo et 
al., 2011).  
Circulating cytokines can be detected in biological fluids during different 
stages of sepsis. The presence of circulating cytokines, however, does not 
necessarily reflect the character and the time of their activity, and their absence 
in the blood or other fluids does not indicate an absence of cytokine production 
by activated cells (Cavaillon et al., 1992). More than 20 different cytokines 
have been evaluated as sepsis biomarkers (Pierrakos & Vincent, 2010; Russel, 
2012; Burkovskiy et al., 2013; Schulte et al., 2013), and several of them were 
studied both in human and animal sepsis (summarized in Table 1). For instance, 
IL-8 is the most studied cytokine in organ injury in sepsis in humans and 
animals (Faleiros et al., 2009), and circulating plasma IL-8 concentrations were 
shown to be increased as a result of endotoxemia in human, primate and 
porcine models of sepsis (Kuhns et al., 1995; VanZee et al., 1991; Toft et al., 
2002). Serum and plasma concentrations of IL-8 were not only increased in 
patients with sepsis, but also correlated positively with the presence of multiple 
organ dysfunctions and were suggested as outcome predictors in severe sepsis 
in humans (Bozza et al., 2007). Moreover, IL-8 concentrations were able to 
accurately predict the onset of sepsis in neonates (Ng & Lam, 2006), and IL-8 
mRNA was one of the most highly upregulated cytokines in uteri from dogs 
with sepsis secondary to uterine bacterial infection (Hagman et al., 2009b). 
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Table 1. Cytokines as sepsis biomarkers 
Cytokine Implication in sepsis Host reference 
TNFα Increased in plasma/serum Human (Munoz et al., 1991), dog 
(DeClue et al., 2012), rat (Ertel et al., 
1991 
Plasma concentrations correlate with 
survival 
Human (Casey et al., 1993; Blackwell 
& Christman, 1996) 
Early marker of endotoxin exposure Dog (Otto, 2007) 
 
Outcome prognosis Human (Oberholzer et al., 2005) 
Organ damage- and mortality-related 
 
Human (Pinsky et al., 1993) 
IL-6 Increased in plasma/serum 
 
 
Human (Munoz et al. 1991), dog 
(DeClue et al., 2012; Floras et al., 
2014), rat (Ertel et al., 1991)  
Increased plasma concentrations 
correlate with survival 
Human (Casey et al., 1993; Blackwell 
& Christman, 1996) 
Outcome prognosis Human (Oberholzer et al., 2005; 
Novotny et al., 2012; Srisangthong et 
al., 2013), dog (Rau et al., 2007) 
Correlate with severity Human (Martins et al., 2003; 
Srisangthong et al., 2013) 
Monitoring immunomodulatory 
therapy efficacy  
 
Dog (Hicks et al., 2012), mouse 
(Osuchowski et al., 2009) 
IFN-γ Increased in serum in septic shock Human (Schulte et al., 2013) 
 
Neutralization increases resistance to 
septic shock 
 
Mouse (Heinzel, 1990; Car et al., 1994) 
IL-4 Low concentrations correlated with 
pneumonia onset  
Human (Scott et al., 2002) 
 
Blockade restore lymphocyte function Mouse (Scott et al., 2002) 
 
IL-7 Lymphocyte survival and function Human (Venet et al., 2012), mouse 
(Unsinger et al., 2010)  
Improves survival Mouse (Unsinger et al., 2010)  
Increased in plasma  Human (Bozza et al., 2007) 
Increased local gene/mRNA 
expression 
 
Dog (Hagman et al., 2009b), mouse 
(Unsinger et al., 2010) 
IL-8/ Onset prediction Human neonates (Ng & Lam, 2006) 
Organ dysfunction and outcome Human (Bozza et al., 2007), horse 
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CXCL8 prediction (Faleiros et al., 2009)  
Increased in plasma/serum  Human (Kuhns et al., 1995), primate 
(VanZee et al., 1991), pig (Toft et al., 
2002), dog (Floras et al., 2014) 
Increased local gene expression Dog (Hagman et al., 2009b) 
 
IL-10 Incresed concentrations in serum 
and/or associated with outcome 
Human (Kellum et al., 2007; Thijs and 
Hack, 1995; Gogos et al., 2000; 
Urbonas et al., 2012; Novotny et al., 
2012), dog (Floras et al., 2014) 
Correlate with severity Human (Wang et al., 2006; Collighan et 
al., 2004; Latifi et al., 2002) 
 
IL-18 Increased in plasma and/or correlated 
with poor outcome 
Human (Tschoeke et al., 2006;  
Grobmyer et al., 2000) 
Discriminate between Gram positive 
and Gram negative sepsis 
Human (Tschoeke et al., 2006) 
Increased local gene expression Dog (Hagman et al., 2009b) 
 
KC/ 
KC-like/ 
CXCL1/ 
GROα 
Survival and bacterial clearance Mouse (Jin et al., 2014) 
Increased mRNA expression Horse (Faleiros et al., 2009) 
Increased in serum at onset Human neonates (Manoura et al., 2010) 
Increased in serum Dog (Floras et al., 2014) 
 
IP-10/ 
CXCL10 
Increased gene/mRNA expression Dog (Frangogiannis et al., 2000; 
Hagman et al., 2009b) 
Increased in serum/plasma and/or 
correlate with severity 
Human (Punyadeera et al., 2010), dog 
(Floras et al., 2014) 
 
HMGB1 Increased systemically in toxic shock Rat (Degryse et al., 2001) 
 
Predict outcome and organ 
dysfunction  
Human (Karlsson et al., 2008; Sundén-
Cullberg et al., 2005; Gibot et al., 2007) 
 
IL-8, also named CXCL8, is a chemokine with a strong chemoattracting 
and activating effects on many immune cells, especially neutrophils, and it is 
therefore thought to play an important role in sepsis pathogenesis (Wang et al., 
2010). IL-8 has been shown to be produced by a variety of cells, both immune 
and nonimmune, including monocytes, macrophages and endothelial cells 
(Baggiolini et al., 1991). In mice and rats the genes encoding IL-8 and one of 
its receptors, CXCR1, are absent (Modi & Yoshimura, 1999). The murine 
keratinocyte-derived chemokine KC, also named CXCL1, is thought to be the 
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functional homolog of IL-8, and its lipopolysaccharide (LPS)-induced 
expression was similar to IL-8 (Singer & Sansonetti, 2004). Mouse KC, 
derived from both hematopoietic and resident cells, was shown to be essential 
for bacterial clearance and survival in mice with CLP-induced sepsis (Jin et al., 
2014). Increased mRNA expression of KC was detected in several tissues in 
experimental sepsis in horses (Faleiros et al., 2009), and serum concentrations 
of KC, also named GRO-α in humans, were significantly increased at onset of 
sepsis in human neonates (Manoura et al., 2010). In dogs, KC gene has not 
been identified, but mouse antibodies against KC detect specifically a protein 
called KC-like in canine body fluids. Concentrations of canine KC-like were 
significantly increased in supernatant from canine mononuclear cells 
stimulated with LPS in vitro (Levin et al., 2014). Interestingly, a study on 
canine experimental LPS-induced endotoxemia showed that both serum 
concentrations of KC-like and IL-8 were significantly elevated 4 h after 
endotoxemia initiation (Floras et al., 2014). The two canine chemokines that 
have the highest amino acid sequence similarity to mouse KC are CXCL5 and 
CXCL7 (Figure 2). The knowledge on the role of these chemokines in sepsis or 
bacterial infection in dogs is, however, limited.  
 
Figure 2. Phylogram tree showing the degree of amino acid sequence similarities between 
selected chemokines and species. Among all proteins known in dogs, CXCL5 and CXCL7 are 
most similar to mouse KC/CXCL1. The phylogram was generated using ClustalW2 at European 
Molecular Biology Laboratory (www.embl.org) 
Human CXCL5, also known as ENA-78, was shown to act on the same 
receptor as mouse KC (Zlotnik & Yoshie, 2000). CXCL5 is an ELR+ CXC 
chemokine that is preformed and stored in platelet granules under homeostatic 
conditions (Semple et al., 2011). In inflammation, however, tissue-resident 
cells are thought to be the main source of circulating CXCL5, as shown in 
cultured human and bovine endometrial cells stimulated with LPS or bacteria 
(MacKintosh et al., 2013; Fischer et al., 2010; Nasu et al., 2001; Bersinger et 
al., 2008) and in E. coli-induced lung inflammation in mice (Mei et al., 2010). 
Mouse CXCL1 
Canine CXCL5 
Mouse CXCL7 
Human CXCL7 
Canine CXCL7 
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In mouse model of sepsis increased plasma CXCL5 concentrations were 
detected within 24 h after cecal ligation and puncture (CLP) (Zhang et al., 
2014). CXCL7, another ELR+ CXC chemokine produced and released by 
platelets, is produced as a precursor peptide pro-platelet basic protein that is 
then cleaved to connective tissue activating peptide III, β-thromboglobulin and 
finally to CXCL7 (Majumdar et al., 1991). CXCL7 has been shown to be a 
more sensitive marker for imaging of E. coli infection in rabbit cells in vitro 
compared to CXCL5 (Rennen et al., 2004), but little is known about the levels 
of CXCL7 in human and veterinary patients with sepsis.  On the contrary, an 
ERL- CXC chemokine CXCL10 was extensively studied in sepsis in both 
humans and dogs. Serum concentrations of CXCL10 were significantly 
increased in dogs 4 hours after experimentally induced endotoxemia, and 
higher levels of CXCL10 mRNA were detected in the heart, lung, kidney, 
liver, and spleen after systemic endotoxin administration (Floras et al., 2014; 
Frangogiannis et al., 2000). 
TNF-α and IL-6 are powerful inducers of coagulation and have been shown 
to be potentially useful as prognostic markers in sepsis (Oberholzer et al., 
2005). TNF-α concentrations were related to both organ damage and mortality 
(Pinsky et al., 1993), and at the same time shown to be useful as an early 
marker for acute endotoxin exposure as shown in experimentally induced 
sepsis in dogs (Otto, 2007). On late stages of sepsis IL-6 correlated with 
disease severity (Martins et al., 2003; Srisangthong et al., 2013) and was 
shown to have a prognostic value in both human and canine sepsis (Novotny et 
al., 2012; Rau et al., 2007; Srisangthong et al., 2013). Concentrations of IL-6 
were shown to be predictive both for early mortality (<48 h) and for mortality 
after 28 days in humans with sepsis (Bozza et al., 2007). Moreover, IL-6 could 
accurately direct immunomodulatory therapy in experimental sepsis in mice 
(Osuchowski et al., 2009) and in dogs with severe staphylococcal pneumonia 
(Hicks et al., 2012).  
IFN-γ is another pro-inflammatory cytokine that together with TNF-α and 
IL-6 was shown to contribute to cytokine storm in sepsis (Huang et al., 2005). 
The neutralization of IFN-γ results in increased resistance to septic shock 
induced by LPS in mice (Heinzel, 1990; Car et al., 1994). IFN-γ is produced 
primarily by activated natural killer cells, Th1 and CD8 T cells, and its 
production is regulated by cytokines such as TNF-α and IL-18 (Schulte et al., 
2013). Although IFN-γ was not shown to correlate with sepsis severity and 
could not predict outcome, it could restore the macrophage function towards 
bacterial stimulation in macrophages isolated from mice with experimental 
sepsis (Flohé et al., 2008), which indicates that a decrease in circulating IFN-γ 
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in patients with sepsis may be associated with the shift towards the 
immunosuppressive stage of the sepsis syndrome.  
IL-7, a potent antiapoptotic cytokine that enhances immune effector cell 
function, was shown to be essential for lymphocyte survival in sepsis 
(Unsinger et al., 2010) and could restore compromised lymphocyte functions 
in human patients with sepsis (Venet et al., 2012). Circulating concentrations 
of IL-7 were more abundant in plasma from critically ill human patients with 
sepsis (Bozza et al., 2007), and IL-7 expression was upregulated in uteri from 
dogs with sepsis caused by uterine bacterial infection (Hagman et al., 2009b). 
IL-7 receptor expression was also increased in an experimental septic mouse 
model (Unsinger et al., 2010).  
Concentrations of IL-10 were increased in patients with sepsis compared to 
healthy humans, and could predict the lethal outcome (Gogos et al., 2000; 
Urbonas et al., 2012; Novotny et al., 2012). IL-10 was also shown to be at 
higher concentrations in patients with septic shock compared to patients with 
earlier stages of sepsis (Wang et al., 2006; Collighan et al., 2004). IL-10 is one 
of the most well described anti-inflammatory cytokines and it was shown to be 
an important regulator of inflammatory response and coagulation in sepsis 
(Cohen, 2010). Many different types of immune cells, including monocytes, 
Th2 and T regulatory cells, can produce IL-10 upon stimulation with a 
pathogen, but its expression is regulated tightly and normally minimal in the 
absence of inflammation (Li et al., 2012). IL-10 is thought be one of the main 
cytokines that can indicate and control the onset of irreversible septic shock 
(Latifi et al., 2002). 
Recent findings show that HMGB1 may also have a potential as sepsis 
biomarker in humans. HMGB1 is a chromatin-binding nuclear factor that is 
normally present in nuclei of most cells and contributes to chromatin 
organization and transcriptional regulation (Bianchi, 2009). In healthy subjects, 
HMGB1 is undetectable in the extracellular environment. However, when cells 
respond to various danger signals, it can be released and readily detectable in 
the circulation acting as DAMP and a cytokine (Cho & Choi, 2014). HMGB1 
can be released in different ways, including active release by immune cells 
such as monocytes and macrophages in response to endotoxin challenge, 
(Wang et al., 1999; Bianchi & Manfredi, 2014), and passive release by necrotic 
non-immune cells both in humans and animals (Bianchi, 2009). Depending on 
its redox state, HMBG1 can act as a chemoattractant and recruit and activate 
myeloid cells (Bianchi & Manfredi, 2014). Moreover, HMBG1 can form 
complexes with other chemokines and promote recruitment and activation of a 
great variety of immune cells (Schiraldi et al., 2012). In sepsis, circulating 
concentrations of HMGB1 were detectable systemically in experimental toxic 
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shock in rats (Degryse et al., 2001) and could predict organ dysfunction and 
outcome in human patients with severe sepsis and septic shock (Karlsson et al., 
2008; Sundén-Cullberg et al., 2005; Gibot et al., 2007).  
Many cytokines seem to have a role in sepsis and their levels provide 
important information that may be useful in diagnosis of sepsis on different 
stages and in different species. However, the potential of all these cytokines to 
distinguish between a controlled local infection and an exacerbated systemic 
syndrome such as sepsis in a clinical setting for both humans and animals 
remains unclear. Moreover, little is known about the levels of sepsis-related 
cytokines in the circulation of animals with naturally occurring sepsis such as 
dogs with pyometra.  
Currently none of the studied biomarkers have been shown to have a 
sufficient diagnostic strength to be routinely used for identification of patients 
with sepsis among those with systemic inflammation at early stages in the 
clinical setting (Pierrakos & Vincent, 2010; Hall et al., 2011; Kibe et al., 2011; 
Henriques-Camacho & Losa, 2014). The clinical setting of sepsis varies, and 
the complexity of sepsis and the comorbidities of patients at risk for sepsis 
make it unlikely that a single biomarker will fulfil all of the requirements. The 
emerging theory is that a panel of biomarkers may better diagnose sepsis 
among patients with systemic inflammation (Pierrakos & Vincent, 2010; Gibot 
et al., 2012). With the recent availability of multiplex platforms allowing 
measuring of several immunological markers in each sample at once, it is now 
feasible that the concentration of panels of biomarkers can be measured both 
experimentally and routinely in the clinics. These new technologies may 
uncover an important knowledge for the improvement of sepsis diagnosis and 
monitoring of sepsis treatment efficiency.  
 
1.2.6 Treatment strategies 
There are no approved drugs that specifically target sepsis, and the treatment is 
limited primarily to support organ function via administration of intravenous 
fluids, antibiotics, and oxygen (Angus & van der Poll, 2013). Broad-spectrum 
antibiotics are used unless the pathogen is identified using blood culture 
(Marik, 2014; Dellinger et al., 2008). Early therapeutic intervention to restore 
balance between oxygen delivery and oxygen demand improved survival 
among patients with severe sepsis (Rivers et al., 2001). An intensive insulin 
therapy to maintain low blood glucose levels resulted in lower morbidity and 
mortality of sepsis patients, regardless of whether they had a history of diabetes 
(Van den Berghe et al., 2001). The protective mechanism of insulin in sepsis is 
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unclear, but insulin was shown to have an antiapoptotic effect (Gao et al., 
2002), and correcting hyperglycemia in patients with sepsis was shown to 
improve bacterial phagocytosis by neutrophils, which is impaired in patients 
with hyperglycemia. However, maintaining such low blood glucose levels (80 
to 110 mg/dl) may put patients at risk for hypoglycemic brain injury. 
Suggested sepsis treatment strategies include also administration of anti-
inflammatory or immunostimulatory agents, depending on the phase of sepsis. 
Recombinant human activated protein C, an anticoagulant, is an anti-
inflammatory agent preventing the generation of thrombin and has been proved 
effective in the treatment of sepsis and reduces the risk of death (Bernard et al., 
2001; Matthay, 2001). Activated protein C inhibits thrombin generation, and 
thus decreases inflammation by inhibiting platelet activation, neutrophil 
recruitment, and mast cell degranulation, blocking cell adhesion and the 
production of cytokines by monocytes. A major risk associated with activated 
protein C is hemorrhage, because activated protein C can cause serious life-
threatening intracranial bleeding (Board, 2002). Currently, the use of activated 
protein C is approved only for use in severe sepsis patients who have multiple 
organ dysfunctions and the highest likelihood of death. Other suggested anti-
inflammatory strategies include inhibition of cytokines such as TNF-α 
(Reinhart & Karzai, 2001) or targeting cytokine receptors by administration of 
IL-1 receptor antagonist (Zeni et al., 1997). Immunostimulatory or immune-
enhancing therapies include the administration of IFN-γ to restore macrophage 
activation (Docke et al., 1997), and IL-12 to induce Th1 cells and restore 
resistance to bacterial challenge (O’Suillebhain et al., 1996). Because the 
effective treatment strategies for different phases of sepsis can be diametrically 
opposite, the precise diagnosis of the phase is crucial for the choice and 
tailoring of the life-saving treatment in sepsis. 
 
1.2.7 How sepsis is studied 
Sepsis has been studied both clinically and experimentally for several decades. 
Most of the clinical studies have focused on patients with severe sepsis or 
septic shock (Mossie, 2013), correlating measured parameters with mortality 
rate as the main outcome. Data from patients at onset and early stages of sepsis 
remains limited, most likely due to the limitations of reliable parameters for 
early sepsis diagnosis.  
Experimental models of sepsis comprise mainly of alteration of the 
endogenous protective barrier that allows bacterial translocation (cecal ligation 
and puncture) in inbred rodents and infusion of large doses of endotoxin or live 
bacteria into the blood stream of an otherwise healthy subject (Buras et al., 
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2005). Unfortunately, none of the existing models can adequately reflect the 
clinical realities of sepsis (Fink & Heard, 1990; Nemzek et al., 2008; Garrido 
et al., 2004; Fink, 2014), which is the main reason for controversy between 
clinical and experimental findings. Important factors such as genetic 
heterogeneity and the high variability of patient’s general condition, which 
comprise the biggest challenge in sepsis diagnosis and treatment, are omitted in 
animal models of sepsis. When large doses of endotoxin or bacteria are infused 
into an otherwise healthy individual, the immune system will react quickly and 
strongly, with exponential increase in levels of many circulating cytokines, 
such as TNF-α, which is most often not the case in patients with sepsis 
(Deitch, 1998). Moreover, experimental sepsis models rarely include 
supportive therapeutic interventions that are common in clinical practice and 
may influence the course of the sepsis syndrome. Altogether, this makes a 
large amount of experimental data not applicable to the clinical practice and 
sometimes misleading (Rittirsch et al., 2007). To solve these problems, a 
model with natural onset and development of sepsis must be enrolled.   
 
1.3 Pyometra – uterine bacterial infection 
Pyometra is a disease caused by an opportunistic bacterial infection of the 
uterus (Hagman et al., 2006a; Smith 2006) and is one of the most common 
bacterial diseases in dogs with incidence over 50% in adult intact dogs of 
certain breeds (Egenvall et al., 2001). On average, nearly 20% of bitches of 
different breeds are expected to get pyometra before the age of 10 years 
(Jitpean et al., 2012). Pyometra occurs less commonly in domestic cats and 
captive large felids, some livestock species, and laboratory animals such as 
rabbits and some strains of mice and rats (Kendziorski et al., 2012). In humans, 
pyometra is an uncommon condition with rare but significant mortality 
resulting from spontaneous uterine perforation or rupture leading to sepsis. In 
the general population, the disease is estimated to account for about 0.04% of 
gynecological admissions; however, the incidence becomes increased to >13% 
in the elderly (Yildizhan et al., 2006). 
Pyometra diagnosis is based on patient history, physical examination 
findings, laboratory blood test results and diagnostic imaging using 
ultrasonography or radiology to demonstrate an enlarged, fluid-filled uterus 
(Hagman et al., 2006a). Uterine enlargement and leukocytosis with 
neutrophilia and left shift are common findings relevant to the diagnosis of 
pyometra, but polyuria/polydipsia, anorexia, depression, vulvar discharge (in 
case of open cervix pyometra) are other classical signs that also are commonly 
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present (Hardy & Osborne, 1974; Jitpean et al., 2014b). Bitches with a closed 
cervix pyometra and only a slight increase in uterine size may be difficult to 
diagnose, especially when leukocytosis is absent. A preliminary diagnosis of 
pyometra can be verified by identifying a pus-filled inflamed uterus during 
surgery in combination with postoperative macroscopic and histopathological 
investigation of the uterus and ovaries and bacterial culturing of the uterine 
content (Hagman, 2012).  
Dogs with pyometra often develop sepsis, i.e. 6 of 10 cases display two or 
more clinical symptoms of SIRS at the time of admission to the animal hospital 
(Fransson et al., 2007). Clinical diagnostic criteria for sepsis in dogs are as 
unspecific as in humans (as described in detail on Page 13) and include 
abnormal heart and respiratory rates, body temperature, blood leucocyte 
concentrations and high percentage of band neutrophils (Hauptman et al., 
1997), making it as difficult to diagnose sepsis in dog with pyometra as in 
human patients with severe infections. Because the inflammatory and 
coagulation changes that accompany severe infections and sepsis in dogs are 
similar to those in humans, dogs have been recognized as a more suitable 
animal species than rodents for studying of sepsis (Otto, 2007), and pyometra 
is lately studied as a natural model of sepsis in dogs (Conti-Patara et al., 2012).  
 
1.3.1 Etiology of pyometra: why and how it occurs 
Exposure to estrogen in combination with high progesterone concentrations in 
the circulation has been shown experimentally to be one of the main triggering 
factors for pyometra initiation, and the incidence of pyometra rises with age 
(Niskanen & Thrusfield, 1998; Egenvall et al., 2001; Kendziorski et al., 2012). 
Genetic factors related to infiltration of leukocytes into the uterus play a major 
role in regulating sensitivity to estrogen-induced uterine inflammation and 
pyometra as shown in rats, dogs and mice (Gould et al., 2005; Hagman et al., 
2011; Roper et al., 1999; respectively). In sensitive strains of laboratory rats 
and mice, it is well established that chronic exposure to estradiol or the highly 
efficacious nonsteroidal estrogen can induce pyometra (Gardner & Allen, 
1937; Gould et al., 2005; Stone et al., 1979). 
Pyometra in dogs is mainly caused by a Gram negative bacteria, in 
particular E. coli, but other types of bacteria and even a combination of 
different bacterial species have also been detected (Hagman et al., 2002). 
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1.3.2 Treatment of pyometra 
The traditional therapy for pyometra is ovariohysterectomy, which is surgical 
removal of the uterus and ovaries. The main advantage of ovariohysterectomy 
is that it removes the source of the disease and is therefore most effective 
considering both cure and prevention of disease recurrence. When a dog with 
pyometra has a severely affected and unstable general condition, possibly due 
to the developed sepsis, an immediate surgical treatment can be life-
threatening. This is why stabilization with treatment including intravenous 
fluids and antimicrobials is necessary, and hormonal treatment is administered 
in such cases prior to surgery to prevent death and serious complications. 
Therefore, a quick and accurate sepsis diagnosis in dogs with pyometra is 
crucial, and it may help to reduce treatment costs associated with pyometra and 
favor the improved life quality of the animals.   
Because the surgery can be associated with high risk of mortality for some 
animals with concurrent diseases and results in permanent infertility, drug-
based treatments of pyometra have emerged, including the administration of 
aglepristone with or without the additional administration of low doses of 
prostaglandins (Fieni et al., 2014; Ros et al., 2014). However, this is only 
prescribed in rare cases, and without surgical removal of the infection source in 
pyometra the risk for disease exacerbation and onset of sepsis remains high.  
 
1.3.3 Biomarkers of sepsis in dogs with pyometra 
Several biomarkers have been evaluated as diagnostic markers in canine sepsis 
(DeClue et al., 2011; Hagman et al., 2006b; Fransson et al., 2007). Increased 
CRP concentrations have been associated with sepsis in canine pyometra 
(Fransson et al., 2007). However, CRP is a biomarker of inflammation caused 
by different kinds of stimuli, and its concentrations are elevated in a large 
number of noninfectious inflammatory conditions (Clyne & Olshaker, 1999). 
Concentrations of prostaglandin F2α metabolite were highly increased in 
bitches with endotoxemia (detectable endotoxin in the blood stream) caused by 
pyometra (Hagman et al., 2006b). Serum amyloid A concentrations were 
significantly higher in dogs with sepsis compared to dogs without sepsis in 
pyometra, but the sensitivity and specificity for detecting sepsis was below 
75% (Jitpean et al., 2014a). Blood lactate and serum albumin concentrations 
could not differentiate between septic and nonseptic dogs with pyometra 
(Hagman et al., 2009a; Conti-Patara et al., 2012; Jitpean et al., 2014a). 
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Cytokines as biomarkers of sepsis in dogs with pyometra 
IL-8 and CXCL10 are among the most extensively studied chemokines of CXC 
chemokine group in dogs (Gangur et al., 2002). It has previously been shown 
that IL-8 and CXCL10 expression is highly upregulated in uteri from dogs with 
sepsis caused by pyometra (Hagman et al., 2009b). Other cytokines locally 
upregulated in dogs with pyometra and sepsis were IL-6, IL-7, IL-10, IL-15, 
IL-18 and TNF-α, but the knowledge on concentrations of these and other 
cytokines in the circulation of dogs with naturally occurring sepsis such as 
dogs with pyometra is limited.   
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2 Present investigations 
2.1 Hypothesis and aims  
The general hypothesis has been that a pattern of sepsis-associated circulating 
cytokines can be identified in dogs with naturally occurring sepsis that, in 
addition to current clinical diagnostic criteria, can be used to diagnose sepsis 
and contribute to improved specificity of sepsis diagnosis at early stages. The 
aim has been to investigate the potential usefulness of several cytokines as 
diagnostic markers for sepsis in dogs with pyometra and SIRS. More specific 
aims were to: 
 
 Investigate the systemic concentrations of cytokines in pyometra and 
sepsis in dogs (Paper I) 
 Investigate the systemic concentrations of KC-like protein compared to 
other cytokines in dogs with pyometra and sepsis (Paper II) 
 Investigate the local effect of E. coli and LPS on the expression of 
chemokines in the canine endometrial cells in vitro (Paper III) 
 Investigate the usefulness of measuring serum high-mobility group box 
1 to differentiate between the presence or absence of sepsis in dogs with 
pyometra (Paper IV) 
 
2.2 Results and Discussion 
2.2.1 Paper I: Cytokines as immunological markers for systemic inflammation 
in dogs with pyometra 
The main aim of this study (Paper I) was to investigate systemic 
concentrations of cytokines in sepsis caused by pyometra in dogs. Using a new 
commercially available canine multiplex cytokine assay, we measured 
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circulating concentrations of cytokines IFN-γ, IL-4, IL-6, IL-7, IL-8, IL-10, IL-
15, IL-18 and TNF-α simultaneously in serum samples from dogs with 
pyometra with signs of SIRS (P+SIRS+) or without (P+SIRS-) and compared 
with healthy controls. We could detect TNF-α, IL-7, IL-15, IL-18 and IL-8 in 
more than 90% and IL-10 in 28% of the samples, whereas only up to 3% of the 
samples had detectable concentrations of IL-4, IL-6 and IFN-γ. This is in 
agreement with other studies employing identical method for multiplexed 
cytokine detection in dogs, which showed that IL-4, IL-6, IFN-γ were among 
the cytokines under detection limit (Bastien et al., 2014; Zois et al., 2012). A 
possible explanation to the limited detection of these cytokines in circulation is 
that their concentrations may peak earlier (IL-6) or later (IL-4) during the 
inflammatory reaction and therefore be low at the time of admission and 
sampling, which would be in line with findings in human patients with sepsis 
(Kellum et al., 2007). 
An earlier report showed an increased serum concentration of IL-10 in dogs 
with pyometra compared to healthy pregnant dogs (Maciel et al., 2014). 
Among samples that had detectable concentrations of IL-10 in the present 
study all were from dogs with pyometra and almost all of them had sepsis, 
indicating that an increased concentration of IL-10 may be one of the 
immunological indications of SIRS in pyometra. However, the differences of 
IL-10 concentrations between P+SIRS+ and P+SIRS- group were not significant. 
Thus, in order to define the role of IL-10 in distinguishing between dogs with 
or without SIRS in pyometra a larger number of subjects in each group and 
possibly also a more sensitive method for IL-10 measurement are needed. The 
concentrations of IL-7 were significantly higher in P+SIRS+ dogs compared to 
healthy controls, but did not differ between P+SIRS- and P+SIRS+ dogs, 
suggesting that IL-7 can be helpful in differentiating dogs with pyometra and 
sepsis from completely healthy dogs but is not a good marker to differentiate 
septic from nonseptic dogs with pyometra. Earlier studies have shown that IL-7 
expression was upregulated in uteri from dogs with sepsis caused by pyometra 
(Hagman et al., 2009b), and plasma IL-7 concentrations were significantly 
elevated in critically ill human patients with sepsis, but not in patients with 
early stages of sepsis (Bozza et al., 2007). This may indicate that there is a 
delay between the local production and the systemic release of IL-7 during 
sepsis and therefore suggesting a limited diagnostic value of IL-7 in early 
stages of sepsis. 
The concentrations of IL-8 were higher in P+SIRS+ compared to P+SIRS- 
dogs, but lower in P+SIRS- dogs compared to healthy controls, which suggests 
that increased IL-8 concentrations could be a sign of sepsis in dogs with 
pyometra. There have been discrepancies regarding the usefulness of IL-8 in 
 37 
sepsis diagnosis, with some reports showing that it can be both an early 
diagnostic and a reliable prognostic sepsis biomarker (Bozza et al., 2007; Ng & 
Lam, 2006; Hack et al., 1992; Harbarth et al., 2001), but others also reporting 
that circulating IL-8 rapidly decreases in patients with sepsis (Söderquist et al., 
1995). Therefore, further investigation on the role of IL-8 in canine infection 
and sepsis is needed. 
The concentrations of TNF-α, IL-15 and IL-18 did not differ between the 
groups but IL-15 and IL-18 correlated significantly with concentrations of IL-
7, suggesting a possible diagnostic value for IL-7, IL-15 and IL-18 in 
identifying systemic inflammation in dogs with pyometra. Moreover, two of 
the dogs from the P+SIRS- group had extraordinarily high concentrations of IL-
7, IL-15 and IL-18, suggesting a possible method artefact, or that these dogs 
may be falsely grouped as SIRS-negative according to conventional clinical 
criteria and possibly were at an early stage of sepsis. IL-18 and IL-15 are 
macrophage-derived cytokines that have been previously implicated in sepsis 
pathogenesis in both humans and dogs (Cohen, 2002; Hagman et al., 2009b). 
However, our data is consistent with a recent report showing that there was no 
difference in IL-15 and IL-18 concentrations in LPS-induced canine sepsis 
compared to placebo-treated healthy dogs (Floras et al., 2014). Taken together, 
these findings imply that although IL-15 and IL-18 may have an important role 
in sepsis pathogenesis, their potential as diagnostic biomarkers in canine sepsis 
remains elusive.  
To assess whether increased concentrations of cytokines measured by 
multiplex assay reflected the inflammatory processes in dogs and were not the 
result of method artefacts, we measured concentrations of CRP using a 
sandwich enzyme-linked immunosorbent assay (ELISA) and compared with 
cytokine patterns. CRP concentrations were significantly higher in dogs with 
pyometra, with and without SIRS, compared with healthy controls, which is in 
line with studies showing an increased CRP in uterine infection in dogs 
(Enginler et al., 2004). We found that concentrations of CRP were positively 
associated with IL-15, which indicated that inflammatory processes caused by 
pyometra were consequently evident using different methods. The association 
between CRP and IL-15 in canine pyometra is an interesting finding and needs 
to be further investigated. 
 
Summary (Paper I): 
 Multiplex cytokine assay allowed to simultaneously determine 
concentrations of 5 out of 9 cytokines in serum from dogs with pyometra 
and healthy dogs. 
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 Concentrations of IL-7 differed significantly between dogs with pyometra 
and healthy dogs. 
 Concentrations of IL-8 were significantly higher in SIRS-positive compared 
to SIRS-negative dogs with pyometra.  
 IL-18 correlated significantly with IL-15, and IL-7 correlated with IL-15 
and IL-18. 
 The results obtained using multiplex assay are in agreement with the 
inflammatory processes in the subjects detected independently of the 
multiplex assay. 
 CRP, IL-7, IL-8, IL-15 and IL-18 may have a role in detection of SIRS 
caused by pyometra in dogs. 
 
2.2.2 Paper II: Serum KC-like chemokine concentrations are significantly 
increased in canine bacterial sepsis 
KC-like is a chemokine that has been recently shown to have increased 
systemic concentrations in experimental canine sepsis (Floras et al., 2014). In 
the present study we aimed to investigate systemic concentrations of KC-like 
compared to other cytokines in serum from dogs with naturally occurring 
sepsis, i.e. as a result of pyometra (Paper II). Special attention was paid to use 
samples that were not thawed prior to analyses and were not stored frozen for 
more than one month. A broadest possible spectrum of different circulating 
cytokines was measured simultaneously. We used dogs with pyometra as a 
natural model for sepsis as previously described and collected serum samples 
from totally 39 dogs, including dogs with pyometra (n=22) and healthy 
controls (n=17). Dogs with pyometra were further grouped into dogs with 
sepsis (n=18) and dogs without sepsis (n=4). The serum concentrations of a 
panel of cytokines, namely KC-like, GM-CSF, IL-2, IL-4, IL-6, IL-7, IL-8, IL-
10, IL-15, IL-18, CXCL10 and TNF-α, were measured using multiplex 
analyses, serum concentrations of CRP were determined using an automated 
immunoturbidimetric assay, and hematological and serum biochemistry 
analyses were also performed to evaluate the overall clinical status of the dogs. 
Global clot strength was measured using thromboelastography.  
Significantly higher serum concentrations of KC-like and higher global clot 
strength were detected in dogs with pyometra as compared to healthy dogs, and 
within the pyometra group, dogs with sepsis had a higher concentration of KC-
like and higher global clot strength compared to dogs without sepsis. This is in 
line with recent studies showing increased circulating KC-like concentrations 
in canine experimental sepsis (Floras et al., 2014), an overactivation of 
coagulation system in patients with sepsis (Levi, 2010; Schouten et al., 2008), 
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and elevated global clot strength in dogs with pyometra (Silins, 2013). We 
showed also that hemoglobin levels were significantly lower in all dogs with 
pyometra regardless of the presence or absence of sepsis compared to healthy 
controls, and correlated negatively with concentrations of KC-like. KC-like is a 
yet undescribed protein in dogs that has been recognized specifically in canine 
biological fluids by mouse antibodies against KC/CXCL1 (Garner et al., 2010; 
Zois et al., 2012; Bastien et al. 2014) and has been detected in higher 
concentrations in serum from dogs with LPS-induced sepsis (Floras et al., 
2014). KC, also known as GRO-α, is a neutrophil chemoattractant that was 
also implicated in human, experimental murine and equine sepsis (Faleiros et 
al., 2009; Manoura et al., 2010; Jin et al., 2014). Interestingly, we found also 
that KC-like concentrations correlated positively with concentrations of CRP, 
hospitalization duration, number of monocytes, concentrations of IL-8, 
percentage band neutrophils and global clot strength. Our data suggest that 
KC-like is a suitable biomarker candidate for sepsis and uterine bacterial 
infection in dogs. Further studies are needed to identify and characterize canine 
KC-like as well as investigate its usefulness in sepsis diagnosis in dogs. 
 
Summary (Paper II): 
 Serum KC-like concentrations and global clot strength were significantly 
increased in dogs with naturally occurring sepsis 
 Serum KC-like concentrations were associated with CRP, hospitalization 
length, number of monocytes, concentrations of IL-8, percentage band 
neutrophils, hemoglobin levels and global clot strength in dogs 
 Serum KC-like could better differentiate between dogs with and without 
sepsis in pyometra compared to serum CRP 
 
2.2.3 Paper III: Pathogenic Escherichia coli and LPS enhance the expression 
of IL-8, CXCL5 and CXCL10 in canine endometrial stromal cells 
It was previously shown that dogs with pyometra and sepsis have higher 
mRNA levels of chemokines, including IL-8, in the uterus (Hagman et al., 
2009b), and in Paper II we demonstrated that serum concentrations of an 
unidentified canine chemokine KC-like were significantly increased in dogs 
with pyometra and sepsis. The aim of this study (Paper III) was to investigate 
the local effect of E. coli and LPS on the expression of chemokines in the 
canine endometrial cells in vitro and to assess whether the stromal part of the 
endometrium express higher levels of chemokines in response to bacterial 
infection.  
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IL-8, CXCL5 and CXCL7 are ELR+ CXC chemokines, which means that 
they are potent neutrophil chemoattractants. mRNA sequences of these 
chemokines have high sequence identity/similarity to mouse KC/CXCL1, 
(75.5%, 77.8% and 88.6%, respectively). IL-8 and CXCL5 were earlier shown 
to be produced at a higher rate in human and bovine endometrium exposed to 
LPS or bacteria (MacKintosh et al., 2013; Fischer et al., 2010; Nasu et al., 
2001), and CXCL7 has been shown to be suitable for imaging of E. coli 
infection in rabbit in vitro (Rennen et al., 2004). In the present study we 
assessed mRNA levels of these chemokines in cultured endometrial stromal 
cells isolated from healthy dogs and exposed to either live pathogenic E. coli 
isolated from uterus of a dog with pyometra, or to LPS. The mRNA levels of 
chemokines were measured using quantitative real-time PCR and showed that 
IL-8 and CXCL5 were upregulated in endometrial stromal cells after 24 h of 
exposure to E. coli or LPS. The levels of CXCL7 were decreased or unaffected. 
Considering the main function known for these chemokines, our results suggest 
that, in response to presence of live Gram negative bacteria or bacterial 
fragments, canine stromal endometrial cells may play an important role in early 
neutrophil recruitment to the site of infection and inflammation.  
CXCL10, or IP-10, is an ELR- CXC chemokine and a T-cell attractant with 
an antimicrobial effect both for Gram positive and Gram negative bacteria. 
Canine CXCL10 mRNA sequence has 50% amino acid sequence identity to 
mouse KC. In the present study we found that mRNA levels of CXCL10 were 
higher both in canine endometrial stromal cells exposed to Gram negative 
bacteria E. coli and in cells exposed to LPS compared to nonstimulated cells. 
This is in agreement with another study showing that CXCL10 mRNA 
expression was induced in heart, lung, kidney, liver, and spleen tissues from 
dogs with induced endotoxemia (Frangogiannis et al., 2000) and may indicate 
that endometrial stromal cells participate in recruitment of T cells during a 
bacterial infection in the uterus. 
To compare the experimental results with the real infection situation in vivo, 
we measured mRNA levels of IL-8, CXCL5, CXCL7 and CXCL10 in uteri 
from dogs with pyometra, and found that IL-8 and CXCL5, but not CXCL7 or 
CXCL10, were significantly higher in dogs with pyometra as compared to 
healthy dogs. Considering the high sequence similarity between canine IL-8, 
CXCL5 and mouse KC, and the fact that KC-like and not IL-8 was increased in 
serum from dogs with pyometra and sepsis (Paper II), our findings may 
indicate that CXCL5 may be the putative canine KC-like protein released from 
the uterus into the blood stream when pyometra in dogs exacerbates into sepsis. 
To unravel the differences and similarities between canine CXCL5 and KC-
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like these chemokines must be further identified and described in dogs. 
However, further studies are needed to identify canine KC-like. 
Our results show that the endometrial stromal cells are capable of releasing 
neutrophil-attracting chemokines in response to bacterial infection in vitro, 
which indicates that these cells may have an important role in neutrophil 
recruitment during bacterial infection of the uterus in vivo. Further studies are 
needed to clarify the role of chemokines in host response to bacterial infection 
in dogs and the possibility of using these chemokines as diagnostic parameters 
for bacterial infection in this species. 
 
Summary (Paper III): 
 Pathogenic uterine-derived E. coli and LPS induce increased CXCL5, 
CXCL10 and IL-8 levels in cultured canine endometrial stromal cells 
within 24 h. 
 mRNA levels of CXCL5 and IL-8 are increased in pyometra-affected uteri 
from dogs. 
 Endometrial stromal cells may have a role in recruitment of neutrophils 
during uterine bacterial infection. 
 
2.2.4 Paper IV: Increased concentrations of C-reactive protein but not high-
mobility group box 1 in dogs with naturally occurring sepsis 
HMGB1 has been shown to act as a proinflammatory cytokine when secreted 
by activated, damaged or killed cells and its systemic concentrations were 
increased in humans with sepsis and in canine model of endotoxemia (Gibot et 
al., 2007; Yu & Park, 2011). The aim of the present study (Paper IV) was to 
investigate the usefulness of systemic concentrations of HMGB1 to 
differentiate the presence and absence of sepsis in dogs with pyometra.  
To find a sepsis-specific biochemical marker that could contribute to more 
accurate and early diagnosis of sepsis in dogs with pyometra, we measured 
serum concentrations of HMGB1 using sandwich ELISA in 23 healthy control 
dogs and 27 dogs with pyometra, 74% of which had sepsis. We also measured 
concentrations of the major acute phase protein CRP using an automated 
immunoturbidimetric assay, and an indicator for endotoxemia, prostaglandin 
F2α metabolite 15-keto-13,14-dihydro-PGF2α (PGM), using 
radioimmunoassay, to assess the relative contribution of HMGB1 to the 
detection of systemic inflammation and natural endotoxemia. We found that 
HMGB1 concentrations, in line with concentrations of CRP and PGM, were 
significantly increased in dogs with pyometra. However, HMGB1 
concentrations did not differ significantly between dogs with sepsis and dogs 
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without sepsis with pyometra. Earlier studies on HMBG1 involvement in 
sepsis showed distinctive levels of HMGB1 in patients with severe sepsis, 
organ failure and septic shock (Gibot et al., 2007; Sundén-Cullberg et al., 
2005; Hatada et al., 2005) and in serum of LPS-treated mice (Wang et al., 
1999), indicating that HMGB1 may be useful as a late marker of sepsis. 
Interestingly, although it was thought that HMGB1 is undetectable in 
extracellular environment of healthy subjects (Cho & Choi, 2014), we could 
detect circulating concentration of HMGB1 not only in dogs with pyometra but 
also in healthy controls.  
The concentrations of CRP were significantly higher in dogs with sepsis 
compared to dogs without sepsis. PGM correlated with concentrations of CRP, 
but did not differ between dogs with and without sepsis in pyometra. Although 
serum HMGB1 was not correlated with either CRP or PGM concentrations, 
HMGB1 was correlated with the total white blood cell counts and was 
increased in dogs after surgery, suggesting an independent regulation and 
involvement of HMGB1 in inflammation. Moreover, serum HMGB1 but not 
CRP concentrations were significantly increased in dogs one day after surgical 
pyometra treatment, ovariohysterectomy. This is in agreement with another 
study showing that HMGB1 concentrations were higher on day one after 
surgery and thereafter decreased, and that the CRP concentrations increased 
first 3 days after ovariohysterectomy in dogs with pyometra (Ishida et al., 
2011). The difference of CRP and HMGB1 concentration patterns in dogs 
indicate that HMGB1 and CRP may have different kinetics in the inflammation 
process caused by surgery and trauma compared to bacterial infection in dogs. 
Also, HMGB1 may have a different turnover than CRP, which makes it useful 
to further investigate the role of HMGB1 in sepsis.  
Our results show that although HMGB1 may have an important role in 
inflammation in dogs with pyometra, its potential as a diagnostic biomarker for 
sepsis in dogs with pyometra is limited.  
 
Summary (Paper IV): 
 Serum concentrations of HMGB1 were detectable in both healthy intact 
female dogs and dogs with pyometra. 
 HMGB1 concentrations were higher in serum from dogs with pyometra 
compared to healthy dogs but did not allow differentiation between the dogs 
with or without SIRS in pyometra. 
 Serum HMGB1 in dogs with pyometra was associated with the well-known 
inflammatory marker CRP as well as with the inflammatory mediator PGM 
previously shown to be an indicator for endotoxemia. 
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 Serum concentrations of HMGB1, and not CRP, were significantly 
increased in dogs with pyometra after surgery. 
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3 Concluding remarks and future 
perspectives 
Dogs with uterine bacterial infection pyometra are one of the most 
physiologically relevant models of naturally occurring sepsis currently studied, 
and canine inflammatory response characteristics are more similar to that of 
humans compared with mouse or rat. We have investigated several biomarkers 
that can improve the specificity of early sepsis diagnosis in clinical setting and 
found that KC-like, CXCL5 and IL-8 are promising candidates. Measured 
repeatedly and simultaneously in a large number of subjects, these chemokines 
may possibly provide a distinctive pattern reflecting different stages of 
bacterial infection and sepsis in dogs with pyometra and accounting for 
individual variations in the clinical symptoms. For instance, if at the time of 
admission a dog with pyometra has no fever and disturbances of heart- and 
respiratory rates, and an increased number of band neutrophils in the blood is 
the only clinically evident criteria for sepsis, an increased serum KC-like 
and/or tissue IL-8 may serve as an additional indicator on that sepsis is 
ongoing. 
KC-like, unidentified and uncharacterized in dogs and yet specifically 
detected at protein level in canine immunoassays using mouse KC antibodies, 
seems to have high potential to discriminate between the presence and absence 
of sepsis in dogs with pyometra. Although CRP is a well-known marker of 
inflammation and one of the most well studied biomarkers in sepsis, it could 
not differentiate between the presence and absence of sepsis in dogs with 
pyometra in the same setting. CXCL5 (or ENA-78) is another chemokine that 
is poorly described in dogs, and at amino acid level it showed highest 
similarity to mouse KC sequence, also called CXCL1. Currently, it is not 
possible to measure circulating concentrations of CXCL5, ENA-78 or CXCL1 
in dogs, but our data in cultured canine endometrial cells exposed to live 
pathogenic E. coli and in uteri from dogs with pyometra demonstrate that the 
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mRNA of CXCL5 is synthesized at a higher rate compared to nonstimulated 
cells and uteri from healthy dogs. Identification of KC-like or CXCL5 in dogs 
is therefore of high interest for bacterial infection and sepsis diagnosis in dogs 
with pyometra. Although mRNA expression of IL-8 was previously shown as 
one of the most elevated in uteri from dogs with pyometra compared to uteri 
from healthy dogs, the circulating protein concentrations of IL-8 in dogs were 
barely useful for the identification of dogs with pyometra or dogs with sepsis in 
pyometra. This may be dependent on the role of IL-8 in sepsis and the timing 
of measurement of circulating IL-8 in naturally occurring sepsis. The local 
synthesis and possibly also release of IL-8 in infected tissues is known to have 
a main purpose of attracting neutrophils to the site of infection. Whether IL-8 
performs this function in collaboration with other neutrophil-attracting 
cytokines such as KC (KC-like) or CXCL5 and therefore has a limited role in 
sepsis pathogenesis or diagnosis in dogs is poorly understood.  
We found that using multiplexing immunologic assays for measuring of 
several biomarkers in one sample at the same time may have its drawbacks, 
including a low or absent detection of certain cytokines such as CXCL10, IL-
10, IL-4 and TNF-α, and high variability within the runs. Multiplexing 
methods available today may therefore have a limited usefulness in the routine 
clinical practice but can be helpful in initial screening for the potential 
biomarker patters for a certain disease including sepsis.  
Other methods evaluating the activation, receptor expression and apoptosis 
rates of immune cells in sepsis can be of potential benefit for identification and 
evaluation of new sepsis biomarkers in dogs with pyometra. For instance, the 
measurement of integrin CD64 and chemokine receptor CXCR2 expression on 
circulating neutrophils, expression of apoptosis markers in neutrophils and 
leukocytes may be of potential use for improving the diagnosis of sepsis in 
dogs. However, both for humans and animals, it may be beneficial that the 
focus is shifted from comparing healthy subjects and patients with sepsis 
towards comparing patients with sepsis and those with non-infectious SIRS, as 
well as comparing patients with local infection and patients at onset of sepsis, 
because the biggest challenge for sepsis diagnosis remains the quick and robust 
differentiation of patients with bacteremia and/or endotoxemia among those 
with an exacerbated inflammation in the absence of infecting agent.  
Dogs with pyometra and sepsis will, as well as human patients with severe 
infections and sepsis, benefit highly from an earlier and specific sepsis 
diagnosis and reduction of unnecessary antibiotic use. Therefore, the findings 
obtained using canine pyometra as a model of sepsis may be beneficial both for 
human and veterinary medicine. 
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4 Populärvetenskaplig sammanfattning 
Sepsis (blodförgiftning) är ett alvarligt inflammatoriskt tillstånd som orsakas 
av en infektion. En sådan systemisk infektion leder till kraftigt sänkt blodtryck, 
massiv inflammation, vävnadsskada, organsvikt, chock och död hos både djur 
och människor. Det är viktigt att diagnostisera sepsis tidigt och exakt för att 
rätt och livräddande behandling ska kunna ges.  
De kliniska kriterierna som används för att diagnosticera sepsis är enbart 
generella såsom kraftiga ändringar i hjärtfrekvens, andningsfrekvens, 
blodtryck, kroppstemperatur och antal neutrofiler eller vita blodkroppar. Dessa 
kliniska symptom kan även tyda på andra patologiska tillstånd förutom sepsis, 
vilket gör att många sepsisdiagnoser blir felaktiga eller försenade. Det finns 
därför ett stort behov av kompletterande diagnostiska kriterier för sepsis. 
Biokemiska markörer, d. v. s. proteiner som naturligt utsöndras i kroppen, som 
är detekterbara i blodomloppet i samband med utveckling av ett septiskt 
tillstånd, skulle kunna komplettera generella kliniska kriterier och bidra till en 
mer specificerad och robust sepsisdiagnos.  
Tikar som inte kastreras i tid får ofta en allvarlig bakterieinfektion i 
livmodern som vanligtvis orsakas av bakterien Escherichia coli och leder till 
sjukdomen som kallas för pyometra. Varje år drabbas ca 10 000 tikar i Sverige 
av pyometra och sjukdomen kan snabbt utvecklas till sepsis om den inte 
behandlas. Tikar som diagnostiseras med pyometra har ofta haft sjukdomen ett 
tag och löper därför stor risk att utveckla sepsis. Närmare 6 av 10 tikar med 
pyometra utvecklar sepsis innan behandlingen är påbörjad. Hundar med 
pågående sepsis måste hjälpas med starka antibiotika innan livmodern får 
opereras bort. Det är viktigt därför att snabbt och exakt bedöma om sepsis är på 
gång i hundar med pyometra. Dessutom har hundarnas inflammatoriska och 
toxikologiska reaktioner flera likheter med motsvarande reaktioner hos 
människor, vilket gör att hundar med pyometra och naturlig sepsis är en 
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mycket värdefull modell för att få kunskap med relevans även för sepsis hos 
människor. 
Vi har studerat femton olika inflammationsmarkörer hos hundar med 
pyometra som sedan utvecklat blodförgiftning och jämfört med hur dessa 
utrycks hos friska hundar. Halter av ett protein som heter KC-like var högre 
hos hundar med pyometra och sepsis jämfört med hos friska hundar. Mängden 
KC-like var också starkt kopplat till flera andra sepsis-relaterade faktorer så 
som blodkoaglets hållfasthet, antal monocyter i blodet, koncentrationen av ett 
känt inflammatoriskt akutfasprotein samt förlängd sjukhusvistelsetid. KC-like 
är ett kemokin, vilket betyder att det är ett signalprotein som attraherar andra 
celler till infektionskällan med hjälp av en kemisk gradient. KC-like är dock 
inte fullständigt identifierad hos hund och lånar därför namnet frånmotsvarande 
KC kemokin hos möss.  
Vi har identifierad att ett annat kemokin hos hund som heter CXCL5 är 
mest lik KC-like i dess proteinsekvens. Vi mätte hur CXCL5 uttrycktes lokalt 
av livmoderceller vid en bakterieinfektion. Livmoderceller från friska hundar 
isolerades, odlades och infekterades med delar från döda bakterier (endotoxin) 
alternativt med levande bakterier (Escherichia coli) som tidigare isolerats från 
en tik med pyometra. En analys av cellernas genuttryck visade att både 
endotoxin och levande bakterier gav förhöjt uttryck av bland annat CXCL5. 
Dessutom kunde vi påvisa ett ökat uttryck av CXCL5 även i livmodervävnad 
från hundar med pyometra. För att kunna avgöra om hundens KC-like är 
samma sak som CXCL5 samt om KC-like eller CXCL5 kan fungera som 
kompletterande diagnostiska markörer för sepsis på hund måste dessa 
signalproteiner beskrivas och testas vidare på en större grupp tikar med 
pyometra och sepsis. 
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